Engineers Gate Manager’s Rubius Therapeutics, Inc RUBY Stock Holding History

Engineers Gate Manager’s Portfolio RUBY Stock Details RUBY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17,022	Closed	-$14K	–	2215
2022 Q2	$14K	Sell	17,022 -1,678	-9%	-$2.82K	﹤0.01%	1835
2022 Q1	$103K	Buy	18,700 +8,151	+77%	+$51.8K	﹤0.01%	1706
2021 Q4	$102K	Buy	+10,549	New	+$146K	﹤0.01%	1806
2021 Q3	–	Sell	-9,011	Closed	-$220K	–	2089
2021 Q2	$220K	Buy	+9,011	New	+$225K	0.01%	1348
2020 Q4	–	Sell	-10,000	Closed	-$50K	–	2071
2020 Q3	$50K	Buy	+10,000	New	+$53K	﹤0.01%	1607
2020 Q2	–	Sell	-10,700	Closed	-$48K	–	2055
2020 Q1	$48K	Buy	+10,700	New	+$79.5K	﹤0.01%	1484

Other funds holding RUBY

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Engineers Gate Manager's RUBY Position: Q3 2022 in Review

Engineers Gate Manager sold out of Rubius Therapeutics, Inc (RUBY) in Q3 2022, closing a stake of 17,022 shares — an estimated $14K sold.

Engineers Gate Manager first reported a position in RUBY in Q1 2020 and held it in 6 quarters. The position peaked at $220K in Q2 2021. 62 funds tracked by Wall St. Rank hold RUBY as of Q3 2022.

Engineers Gate Manager reported no remaining Rubius Therapeutics, Inc position as of Q3 2022 after selling out during the quarter.
Engineers Gate Manager sold 17,022 Rubius Therapeutics, Inc shares in Q3 2022, an estimated $14K.
Engineers Gate Manager first reported a position in Rubius Therapeutics, Inc in Q1 2020 and held it in 6 quarters.
Engineers Gate Manager's Rubius Therapeutics, Inc position peaked at $220K in Q2 2021.
62 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q3 2022.

Based on Engineers Gate Manager's 13F filing for Q3 2022, filed 14 Nov 2022.